[Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
Active and adoptive immunotherapy as an adjunct to surgical treatment in non-small cell lung cancers was analysed, based on the results of our TF experiences and a literature review, and its significance was discussed.